413 related articles for article (PubMed ID: 17229858)
1. COBAS AmpliPrep-COBAS TaqMan hepatitis B virus (HBV) test: a novel automated real-time PCR assay for quantification of HBV DNA in plasma.
Allice T; Cerutti F; Pittaluga F; Varetto S; Gabella S; Marzano A; Franchello A; Colucci G; Ghisetti V
J Clin Microbiol; 2007 Mar; 45(3):828-34. PubMed ID: 17229858
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the Cobas Ampliprep/Cobas TaqMan HBV Test versus the Cobas Amplicor HBV monitor for HBV-DNA detection and quantification during antiviral therapy.
Allice T; Cerutti F; Pittaluga F; Varetto S; Gabella S; Marzano A; Franchello A; Ghisetti V
New Microbiol; 2008 Jan; 31(1):27-35. PubMed ID: 18437839
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the COBAS AmpliPrep-total nucleic acid isolation-COBAS TaqMan hepatitis B virus (HBV) quantitative test and comparison to the VERSANT HBV DNA 3.0 assay.
Ronsin C; Pillet A; Bali C; Denoyel GA
J Clin Microbiol; 2006 Apr; 44(4):1390-9. PubMed ID: 16597867
[TBL] [Abstract][Full Text] [Related]
4. Fully automated quantitation of hepatitis B virus (HBV) DNA in human plasma by the COBAS AmpliPrep/COBAS TaqMan system.
Hochberger S; Althof D; Gallegos de Schrott R; Nachbaur N; Röck H; Leying H
J Clin Virol; 2006 Apr; 35(4):373-80. PubMed ID: 16461000
[TBL] [Abstract][Full Text] [Related]
5. Dynamic comparison between Daan real-time PCR and Cobas TaqMan for quantification of HBV DNA levels in patients with CHB.
Cai SH; Lv FF; Zhang YH; Jiang YG; Peng J
BMC Infect Dis; 2014 Feb; 14():85. PubMed ID: 24528480
[TBL] [Abstract][Full Text] [Related]
6. Preemptive adefovir versus lamivudine for prevention of hepatitis B reactivation in chronic hepatitis B patients undergoing chemotherapy.
Ho EY; Yau T; Rousseau F; Heathcote EJ; Lau GK
Hepatol Int; 2015 Apr; 9(2):224-30. PubMed ID: 25788197
[TBL] [Abstract][Full Text] [Related]
7. Performance of the Cobas AmpliPrep/Cobas TaqMan real-time PCR assay for hepatitis B virus DNA quantification.
Chevaliez S; Bouvier-Alias M; Laperche S; Pawlotsky JM
J Clin Microbiol; 2008 May; 46(5):1716-23. PubMed ID: 18287319
[TBL] [Abstract][Full Text] [Related]
8. Performance of version 2.0 of the Cobas AmpliPrep/Cobas TaqMan real-time PCR assay for hepatitis B virus DNA quantification.
Chevaliez S; Bouvier-Alias M; Laperche S; Hézode C; Pawlotsky JM
J Clin Microbiol; 2010 Oct; 48(10):3641-7. PubMed ID: 20720031
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the QIAGEN artus HBV QS-RGQ Assay With the Roche COBAS AmpliPrep/COBAS TaqMan HBV Assay for Quantifying Viral DNA in Sera of Chronic Hepatitis B Patients.
Han MS; Park Y; Nah H; Kim HS
Ann Lab Med; 2017 May; 37(3):248-253. PubMed ID: 28224771
[TBL] [Abstract][Full Text] [Related]
10. Verification of the Roche cobas
Tan NK; Carrington D; Pope CF
J Med Microbiol; 2018 Dec; 67(12):1711-1717. PubMed ID: 30325300
[TBL] [Abstract][Full Text] [Related]
11. Safety and efficacy of adefovir therapy for lamivudine-resistant hepatitis B virus infection in renal transplant recipients.
Lai HW; Chang CC; Chen TH; Tsai MC; Chen TY; Lin CC
J Formos Med Assoc; 2012 Aug; 111(8):439-44. PubMed ID: 22939662
[TBL] [Abstract][Full Text] [Related]
12. Clinical course and predictive factors of virological response in long-term lamivudine plus adefovir dipivoxil combination therapy for lamivudine-resistant chronic hepatitis B patients.
Aizawa M; Tsubota A; Fujise K; Tatsuzawa K; Kono M; Hoshina S; Tajiri H
J Med Virol; 2011 Jun; 83(6):953-61. PubMed ID: 21503906
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of entecavir in patients with chronic hepatitis B resistant to both lamivudine and adefovir or to lamivudine alone.
Shim JH; Suh DJ; Kim KM; Lim YS; Lee HC; Chung YH; Lee YS
Hepatology; 2009 Oct; 50(4):1064-71. PubMed ID: 19637288
[TBL] [Abstract][Full Text] [Related]
14. Entecavir 1mg versus combined lamivudine/adefovir dipivoxil in chronic HBV Egyptian patients resistant to LAM monotherapy, non-randomised controlled study.
Maklad S; Doss W; El Din SS; Hassan K; Zeid AA
Arab J Gastroenterol; 2014 Mar; 15(1):1-5. PubMed ID: 24630505
[TBL] [Abstract][Full Text] [Related]
15. Performance of the cobas Hepatitis B virus (HBV) test using the cobas 4800 system and comparison of HBV DNA quantification ability between the COBAS AmpliPrep/COBAS TaqMan HBV test version 2.0 and cobas HBV test.
Shin KH; Lee HJ; Chang CL; Kim HH
J Clin Virol; 2018 Apr; 101():47-51. PubMed ID: 29414188
[TBL] [Abstract][Full Text] [Related]
16. Serum hepatitis B surface antigen quantitation can reflect hepatitis B virus in the liver and predict treatment response.
Chan HL; Wong VW; Tse AM; Tse CH; Chim AM; Chan HY; Wong GL; Sung JJ
Clin Gastroenterol Hepatol; 2007 Dec; 5(12):1462-8. PubMed ID: 18054753
[TBL] [Abstract][Full Text] [Related]
17. Randomized comparison of tenofovir disoproxil fumarate vs emtricitabine and tenofovir disoproxil fumarate in patients with lamivudine-resistant chronic hepatitis B.
Fung S; Kwan P; Fabri M; Horban A; Pelemis M; Hann HW; Gurel S; Caruntu FA; Flaherty JF; Massetto B; Dinh P; Corsa A; Subramanian GM; McHutchison JG; Husa P; Gane E
Gastroenterology; 2014 Apr; 146(4):980-8. PubMed ID: 24368224
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the COBAS TaqMan HBV test with the COBAS Amplicor monitor test for measurement of hepatitis B virus DNA in serum.
Sum SS; Wong DK; Yuen JC; Lai CL; Yuen MF
J Med Virol; 2005 Dec; 77(4):486-90. PubMed ID: 16254975
[TBL] [Abstract][Full Text] [Related]
19. A novel fully automated system for quantification of Hepatitis B virus DNA using magnetic bead-based method combined with real-time PCR.
Li WJ; Xu HX; Wu DS; Wu YJ; Xu WD
J Virol Methods; 2017 Oct; 248():130-135. PubMed ID: 28687436
[TBL] [Abstract][Full Text] [Related]
20. Intrahepatic response markers in chronic hepatitis B patients treated with peginterferon alpha-2a and adefovir.
Takkenberg B; Terpstra V; Zaaijer H; Weegink C; Dijkgraaf M; Jansen P; Beld M; Reesink H
J Gastroenterol Hepatol; 2011 Oct; 26(10):1527-35. PubMed ID: 21557773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
